Phase 1 and 2 Study of PX-866 and Cetuximab
Condition(s):Incurable Metastatic Colorectal Carcinoma; Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckLast Updated:May 16, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Incurable Metastatic Colorectal Carcinoma; Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckLast Updated:May 16, 2018Completed
Condition(s):Cutaneous Squamous Cell CarcinomaLast Updated:October 16, 2012Completed
Condition(s):Cutaneous Basal Cell; Squamous Cell CarcinomaLast Updated:September 21, 2023Active, not recruiting
Condition(s):Actinic KeratosisLast Updated:February 7, 2022Completed
Condition(s):Uterine Cervical NeoplasmsLast Updated:June 26, 2015Unknown status
Condition(s):Basal Cell Carcinoma; Squamous Cell CarcinomaLast Updated:April 4, 2016Terminated
Condition(s):Squamous Cell Carcinoma; Basal Cell CarcinomaLast Updated:December 23, 2010Unknown status
Condition(s):Head and Neck Squamous Cell Carcinoma; Glottic T1Last Updated:March 21, 2022Unknown status
Condition(s):Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Oropharynx Cancer; Oropharynx Squamous Cell Carcinoma; HPV Positive Oropharyngeal Squamous Cell CarcinomaLast Updated:February 21, 2024Not yet recruiting
Condition(s):Squamous Cell Carcinoma of the AnusLast Updated:June 3, 2015Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.